Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Whitehawk Therapeutics (WHWK) Shares Outstanding (2018 - 2023)

Historic Shares Outstanding for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q2 2023 value amounting to $24.5 million.

  • Whitehawk Therapeutics' Shares Outstanding rose 1666.75% to $24.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $24.5 million, marking a year-over-year increase of 1666.75%. This contributed to the annual value of $24.4 million for FY2022, which is 1694.19% up from last year.
  • According to the latest figures from Q2 2023, Whitehawk Therapeutics' Shares Outstanding is $24.5 million, which was up 1666.75% from $24.4 million recorded in Q1 2023.
  • In the past 5 years, Whitehawk Therapeutics' Shares Outstanding registered a high of $40.6 million during Q1 2019, and its lowest value of $7212.0 during Q1 2020.
  • Over the past 5 years, Whitehawk Therapeutics' median Shares Outstanding value was $20.9 million (recorded in 2022), while the average stood at $19.1 million.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Shares Outstanding tumbled by 9998.22% in 2020, and later skyrocketed by 28945906.82% in 2021.
  • Whitehawk Therapeutics' Shares Outstanding (Quarter) stood at $7.2 million in 2019, then crashed by 99.9% to $7212.0 in 2020, then soared by 289625.46% to $20.9 million in 2021, then increased by 16.94% to $24.4 million in 2022, then rose by 0.35% to $24.5 million in 2023.
  • Its last three reported values are $24.5 million in Q2 2023, $24.4 million for Q1 2023, and $24.4 million during Q4 2022.